Shire plc - American Depositar

SHPG 
(NASDAQ) 
 
$ 170.12
Updated 09:43:21
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 889
High $ 171.14
Low $ 168.66
Open $ 170.53
ISIN
Prev close $ 172.75
# of shares 304.94M
Market cap 51,876M USD
Intraday

Market closed
Shire plc - American Depositar
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  170.12 -0.8% Stock price decreasing -5.7% Stock price decreasing -0.1% Stock price decreasing 6.0% Stock price increasing 14.6% Stock price increasing
Powered by TradingView

News about Shire plc - American Depositar

  • English
  • Regulatory news

Company profile

Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
11 December 2018 09:58:27
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181207.1 - EUROWEB7 - 2018-12-11 10:58:27 - 2018-12-11 09:58:27 - 1000 - Website: OKAY